We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Interferon-Induced Protein Protects Against Recurring Influenza Infections

By LabMedica International staff writers
Posted on 14 Feb 2013
Following infection of the body by the influenza virus, protective immune cells called resident memory T-cells (TRM cells) are stationed in lung and respiratory mucosal tissues where they express a specific membrane protein that helps prevent reinfection.

Investigators at the University of Melbourne (Australia) reported in the January 27, 2013, online edition of the journal Nature Immunology that infection with influenza virus resulted in the deposition of anti-influenza CD8+ TRM cells in the lung mucosal tissue. More...
These TRM cells selectively maintained expression of the interferon-induced transmembrane protein IFITM3 (interferon-induced transmembrane protein 3).

IFITM3 is an interferon-induced membrane protein that helps confer immunity to influenza A H1N1 virus, West Nile virus, and Dengue virus. It has been reported to play a critical role in the immune system's defense against swine flu, where heightened levels of IFITM3 kept viral levels low, and the removal of IFITM3 allowed the virus to multiply unchecked. This observation was further advanced by a recent study that showed that a single nucleotide polymorphism (SNP) in the human IFITM3 gene that increased influenza susceptibility was overrepresented in people hospitalized with pandemic H1N1.

“If we learn how to increase the number and longevity of T-cells expressing IFITM3, this could lead to improved vaccines that promote the generation of more resistant T-cells able to provide the greatest protection, for longer,” said senior author Dr. JoseVilladangos, professor of microbiology and immunology at the University of Melbourne.

Related Links:
University of Melbourne



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.